Vimarsana
Biggest News Aggregation in the World

Page 11 - Downstream Processing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Downstream Processing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Downstream Processing Today - Breaking & Trending Today

Viral Vector Manufacturing for Cell and Gene Therapies: Plug-and-Play Platform Technologies Enhance the Manufacturing Workflow - Vimarsana News

Viral Vector Manufacturing for Cell and Gene Therapies: Plug-and-Play Platform Technologies Enhance the Manufacturing Workflow

/PRNewswire/ -- The "Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies" report has been added to ResearchAndMarkets.com's...

Downstream Processing Market Revenue Trends, Company Profiles, Revenue Share Analysis, 2020-2027 - Vimarsana News

Downstream Processing Market Revenue Trends, Company Profiles, Revenue Share Analysis, 2020-2027

Downstream Processing Market Revenue Trends, Company Profiles, Revenue Share Analysis, 2020–2027

Downstream Processing Market Revenue Trends, Company Profiles, Revenue Share Analysis, 2020-2027 - Vimarsana News

Downstream Processing Market Revenue Trends, Company Profiles, Revenue Share Analysis, 2020-2027

Downstream Processing Market Revenue Trends, Company Profiles, Revenue Share Analysis, 2020–2027

Vaccine manufacturing campus opens in South Africa - Vimarsana News

Vaccine manufacturing campus opens in South Africa

A new vaccine manufacturing plant was opened in Cape Town by South Africa president Cyril Ramaphosa yesterday.

Researchers set out novel anion exchange membrane chromatography method for separating empty and full adeno-associated virus - Vimarsana News

Researchers set out novel anion exchange membrane chromatography method for separating empty and full adeno-associated virus

Adeno-associated virus (AAV) hold potential for use in numerous gene therapies: with demand only set to grow as more therapies are developed and approved. However, supply of AAV is one of the challenges for the sector. In a study published in Biotechnology Journal last month, researchers outline a new scalable process for separating empty and full particles.